{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:29:44Z","timestamp":1762918184286,"version":"3.44.0"},"reference-count":31,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,11,18]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>A 30-year-old man with no significant previous or family psychiatric history became severely anxious about his health after a positive COVID-19 test. Physical symptoms of COVID-19 were mild, with no evidence of hypoxia or pneumonia, throughout his illness. He was admitted to a quarantine facility. He remained highly anxious, and 1\u2009week later, he developed paranoid delusions and auditory hallucinations (his first psychotic episode). He was treated with lorazepam 1\u2009mg four times a day, mirtazapine 30\u2009mg nocte and risperidone 1\u2009mg two times a day. His psychotic symptoms lasted 1\u2009week. He stopped psychiatric medication after 4 weeks and had remained well when reviewed 3 months later. A Diagnostic and Statistical Manual of Mental Disorders fifth edition diagnosis of brief psychotic disorder with marked stressor (brief reactive psychosis) was made. Anxiety about his health and social isolation appeared the main aetiological factors but an inflammatory component cannot be excluded. The case highlights that first episode psychosis can be associated with mild COVID-19.<\/jats:p>","DOI":"10.1136\/bcr-2020-240088","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T17:41:44Z","timestamp":1608140504000},"page":"e240088","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Brief psychotic disorder associated with quarantine and mild COVID-19"],"prefix":"10.1136","volume":"13","author":[{"given":"Peter M","family":"Haddad","sequence":"first","affiliation":[{"name":"Psychiatry, Hamad Medical Corporation, Doha, Qatar"},{"name":"Clinical Department, College of Medicine, QU Health, Qatar University, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Al Abdulla","sequence":"additional","affiliation":[{"name":"Clinical Department, College of Medicine, QU Health, Qatar University, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Latoo","sequence":"additional","affiliation":[{"name":"Psychiatry, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousaf","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Clinical Department, College of Medicine, QU Health, Qatar University, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"2025082802471338000_13.12.e240088.1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s42269-020-00341-9","article-title":"An overview on COVID-19: reality and expectation","volume":"44","author":"Hamed","year":"2020","journal-title":"Bull Natl Res Cent"},{"key":"2025082802471338000_13.12.e240088.2","unstructured":"World Health Organization . Director-General\u2019s Opening Remarks at the Media Briefing on COVID-19, 2020. Available: https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-themedia-briefing-on-covid-19 [Accessed 11 Mar 2020]."},{"key":"2025082802471338000_13.12.e240088.3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.psym.2020.05.012","article-title":"COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response?","volume":"61","author":"Ferrando","year":"2020","journal-title":"Psychosomatics"},{"key":"2025082802471338000_13.12.e240088.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113254","article-title":"Psychotic symptoms in COVID-19 patients. A retrospective descriptive study","volume":"291","author":"Parra","year":"2020","journal-title":"Psychiatry Res"},{"key":"2025082802471338000_13.12.e240088.5","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236940","article-title":"COVID-19-associated brief psychotic disorder","volume":"13","author":"Smith","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2025082802471338000_13.12.e240088.6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236123","article-title":"Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode","volume":"13","author":"Mawhinney","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2025082802471338000_13.12.e240088.7","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113115","article-title":"Affective psychosis after COVID-19 infection in a previously healthy patient: a case report","volume":"290","author":"Correa-Palacio","year":"2020","journal-title":"Psychiatry Res"},{"key":"2025082802471338000_13.12.e240088.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30460-8"},{"key":"2025082802471338000_13.12.e240088.9","article-title":"Psychosis in patients in COVID-19-Related quarantine: a case series","volume":"22","author":"Finatti","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"2025082802471338000_13.12.e240088.10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.rpsm.2020.04.009","article-title":"Reactive psychoses in the context of the COVID-19 pandemic: clinical perspectives from a case series","volume":"13","author":"Vald\u00e9s-Florido","year":"2020","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"2025082802471338000_13.12.e240088.11","doi-asserted-by":"publisher","DOI":"10.1086\/424016"},{"key":"2025082802471338000_13.12.e240088.12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2020.06.029","article-title":"The hypercoagulable state in COVID-19: incidence, pathophysiology, and management","volume":"194","author":"Abou-Ismail","year":"2020","journal-title":"Thromb Res"},{"key":"2025082802471338000_13.12.e240088.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01957-4","article-title":"Neurological consequences of COVID-19: what have we learned and where do we go from here?","volume":"17","author":"Jarrahi","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2025082802471338000_13.12.e240088.14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.1.e73"},{"key":"2025082802471338000_13.12.e240088.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.062"},{"key":"2025082802471338000_13.12.e240088.16","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2025082802471338000_13.12.e240088.17","unstructured":"World Health Organisation . Clinical management of COVID-19. interim guidance. 27 may 2020. who reference number: WHO\/2019-nCoV\/clinical\/2020.5. Available: https:\/\/www.who.int\/publications\/i\/item\/clinical-management-of-covid-19 [Accessed 9 Oct 2020]."},{"key":"2025082802471338000_13.12.e240088.18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0269881116681399","article-title":"Low doses of mirtazapine or quetiapine for transient insomnia: a randomised, double-blind, cross-over, placebo-controlled trial","volume":"31","author":"Karsten","year":"2017","journal-title":"J Psychopharmacol"},{"key":"2025082802471338000_13.12.e240088.19","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"2025082802471338000_13.12.e240088.20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S2215-0366(19)30124-5","article-title":"Mental health research in the Arab region: challenges and call for action","volume":"6","author":"Maalouf","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"2025082802471338000_13.12.e240088.21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/7854_2018_88","article-title":"Oxidative stress and cellular markers of inflammation in schizophrenia","volume":"44","author":"Upthegrove","year":"2019","journal-title":"Curr Top Behav Neurosci"},{"key":"2025082802471338000_13.12.e240088.22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.25807","article-title":"COVID-19: a global threat to the nervous system","volume":"88","author":"Koralnik","year":"2020","journal-title":"Ann Neurol"},{"key":"2025082802471338000_13.12.e240088.23","unstructured":"World Health Organization . International classification of mental health and behavioural disorders. 10th edn. Geneva: World Health Organization, 1992."},{"key":"2025082802471338000_13.12.e240088.24","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291702005408"},{"key":"2025082802471338000_13.12.e240088.25","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950040038005"},{"key":"2025082802471338000_13.12.e240088.26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/09540261.2012.715579","article-title":"Acute and transient psychotic disorders: an overview of studies in Asia","volume":"24","author":"Udomratn","year":"2012","journal-title":"Int Rev Psychiatry"},{"key":"2025082802471338000_13.12.e240088.27","unstructured":"Stephen A , Lui F . Brief Psychotic Disorder. In: StatPearls [Internet. Treasure Island (FL: StatPearls Publishing, 2020."},{"key":"2025082802471338000_13.12.e240088.28","unstructured":"Mojtabai R . Brief psychotic disorder. In: Friedman M , ed. UpToDate, 2020. https:\/\/www.uptodate.com\/contents\/brief-psychotic-disorder\/contributors"},{"key":"2025082802471338000_13.12.e240088.29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881119889296","article-title":"Evidence-Based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British association for psychopharmacology","volume":"34","author":"Barnes","year":"2020","journal-title":"J Psychopharmacol"},{"key":"2025082802471338000_13.12.e240088.30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jamapsychiatry.2015.2313","article-title":"Prognosis of brief psychotic episodes: a meta-analysis","volume":"73","author":"Fusar-Poli","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"2025082802471338000_13.12.e240088.31","doi-asserted-by":"crossref","DOI":"10.1186\/1744-859X-13-4","article-title":"A prospective follow-up study of first-episode acute transient psychotic disorder in Latvia","volume":"13","author":"Rusaka","year":"2014","journal-title":"Ann Gen Psychiatry"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-240088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:47:26Z","timestamp":1756374446000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-240088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,16]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/bcr-2020-240088"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-240088","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}